Four HHMI investigators, an HHMI early career scientist, and a senior fellow at Janelia Farm have been elected to the IOM.
The discovery of an odd couple of genes that team up to trigger rare and difficult-to-detect gastrointestinal stromal tumors could eventually lead to better diagnostics and treatments.
Researchers are inching their way toward a new HIV vaccine strategy by studying the cells of people who have naturally strong immune defenses against the virus.
HHMI and the Gordon and Betty Moore Foundation announce a new partnership to support some of the nation's most innovative plant scientists.
Jeffrey Friedman and Douglas Coleman are being honored for discoveries that led to the identification of leptin, a hormone that regulates appetite and body weight.
Mutations that supercharge a cellular garbage disposal may explain why cancer cells can thrive even as their genetic material multiplies out of control.
A targeted search combined with today's rapid DNA sequencing technology leads researchers to a genetic culprit for a rare disease.
Researchers have new details of how an enzyme helps bacteria slice up foreign genetic material.
Most of the clear cell ovarian carcinoma samples examined in a new study carried a gene mutation that alters the epigenetics of cells.
HHMI researchers have found that malaria parasites can produce multiple versions of a protein that causes infected blood cells to grab onto the inner wall of blood vessels.
Multiple jury prizes were awarded in recognition of contributions advancing technology to automate an important but tedious component of neuroscience research.
If Howard Chang has his way, there will soon be an iPhone app for dialing in RNA structures.
A handful of antibiotic-resistant bacteria can protect an entire colony.
A rare skin disease provides the first example of a disease-causing mutation that spontaneously reverts, producing healthy skin.
With the help of yeast and fruit flies, researchers have identified a distorted gene that appears to be among the most common genetic risk factors for amyotrophic laterial sclerosis (ALS), the devastating neurodegenerative disease also known as Lou Gehrig's disease.
Health officials have held off from recommending an inexpensive malaria drug for widespread use because of concerns about drug resistance. New research drawn from 10 years of field and laboratory studies suggests the drug may be a safe and effective way to prevent malaria.
HHMI researchers develop tiny life-support packets for therapeutic cells.
A cooperative online game has attracted 50,000 players whose “distributed thinking” has, in some cases, proven more powerful than computers in predicting the structure of proteins.
A type of prostate cell that has been largely ignored by cancer researchers can trigger malignant prostate cancer.
Janelia Farm researchers show it takes steady hands to measure the brain activity of a fruit fly while it is walking.
HHMI researchers discover that induced pluripotent stem cells retain a genetic memory of their tissue of origin.
A protein that is already the target of experimental drugs that aim to extend life is now known to play a key role in learning and memory.
An ambitious new analysis in mice demonstrates that for more than 1,300 genes active in the brain, there is a significant bias as to which copy is active—the one inherited from the mother or the one that came from the father.
Researchers have identified signaling pathways by which the normal prion protein switches on the general protein synthesis necessary to promote the growth and development of brain cells.
A new imaging method will allow researchers to study speedy cell processes over hours and days rather than seconds, and to examine how morphological defects arise in developing animals.